FDA Investigator Gabrielle J Swain
Gabrielle J Swain has inspections in 2 countries as of 30 Nov 2023. Gabrielle J Swain has collaborated with a combined 1269 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
40
Last Inspection Date:
30 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Italy,
United States of America
Co-Investigator(s):
Amy M Cramer,
Ana P Barido,
Anastasia I Offordile,
Anastasia I Onuorah,
Ann Marie Montemurro,
Anthony C Warchut,
Byungja E Marciante,
CDR Rochelle B Young, RPh, MSA,
Christine M Smith,
Christopher Bastedo,
Christopher Janik,
Chunsheng Cai, PhD,
Cynthia A Harris, MD, RN,
Danielle S Pearson,
Darin S Wiegers,
Deanne E Knapp,
Denis Mackey,
Diane C Thibodeau,
Dien N Nguyen,
Dr. Deanne Knapp,
Edmund F Mrak, Jr,
Edward J Janik,
Ellen A Humphrey,
Erin L Mcfiren,
Gayle S Lawson,
Hang N Guo,
Hector J Colon Torres,
James M Simpson,
James P Mcevoy,
Jeanne J Thai,
John Dan,
Jonah S Ufferfilge,
Joseph L Despins, PhD,
Joseph S Fanelli,
Kelly N Kerr,
Kenneth Nieves,
Kent A Conforti,
Kimberly A Dux,
Kristin M Abaonza,
Lance M De Souza, MBA,
LCDR Margaret E Digennaro,
Lori S Lawless,
Lucila B Nwatu,
Lucilla Facchin,
M Patriciaurphy Murphy,
Marc S Neubauer,
Marcelo O Mangalindan, Jr,
Margaret M Sands,
Mark R Mcclain,
Matthew C Watson,
Maya M Davis,
Merideth K Rose,
Michael J Nerz,
Michelle M Noe,
Mike M Rashti,
Nealie C Newberger,
Nebil A Oumer,
Nina Yang,
Patrick C Klotzbuecher,
Peter R Lenahan,
Rapti D Madurawe,
Stephanie Mangigian, MS/OSH, RN,
Stephen R Souza,
Susanne M Richardson, MSc RAC ELS,
Tania E Vizcaino,
Vaishali J Patel,
Victoria M Daddeo,
William V Millar
Gabrielle J Swain's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2021 | FDA 483 | DERMDOX CENTERS FOR DERMATOLOGY - Form 483, 2021-01-21 |
January, 2023 | FDA 483 | ACROTECH BIOPHARMA, Inc - Form 483, 2023-01-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more